These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2763196)

  • 1. [Activation of the complement system in dilated cardiomyopathy].
    Nasonov EL; Samsonov MIu; Aleksandrova LZ; Masenko VP; Ovtrakht NV
    Ter Arkh; 1989; 61(4):59-63. PubMed ID: 2763196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxins in dilated cardiomyopathy.
    Samsonov M; Nassonov E; Masenko V; Naumov V; Mareev V; Belenkov Y
    J Intern Med; 1993 Aug; 234(2):139-42. PubMed ID: 8340735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of heart rhythm and conduction in dilated and hypertrophic cardiomyopathies].
    Vangeli RS; Naumov VG; Grigor'iants RA; Shevliagin SA; al-Shaer A
    Ter Arkh; 1985; 57(4):57-9. PubMed ID: 4040273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of immunological studies in various forms of cardiomyopathy].
    Iurenev AP; Chumburidze VB; Polianskaia IS; Iazdovskiĭ VV; Krukovskaia ZV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):101-6. PubMed ID: 3501296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies to the myelin major protein in patients with dilated cardiomyopathy. Determination and diagnostic significance].
    Aleksandrova LZ; Samsonov MIu; Titov VN; Nasonov EL; Mukharliamov NM
    Lab Delo; 1989; (1):41-6. PubMed ID: 2468026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
    Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of complement activation during membrane-based plasmapheresis procedures.
    Burnouf T; Eber M; Kientz D; Cazenave JP; Burkhardt T
    J Clin Apher; 2004; 19(3):142-7. PubMed ID: 15493055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The etiology and pathogenesis of dilated cardiomyopathy].
    Gandzha IM; Fedotov AF; Giatos EP
    Vrach Delo; 1989 Nov; (11):68-70. PubMed ID: 2609588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in plasma complement levels after human ischemic stroke.
    Mocco J; Wilson DA; Komotar RJ; Sughrue ME; Coates K; Sacco RL; Elkind MS; Connolly ES
    Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum neopterin in dilated cardiomyopathy].
    Nasonov EL; Samsonov MIu; Masenko VP; Aleksandrova LZ; Kostin SI; Samko AN; Naumov VG
    Ter Arkh; 1990; 62(4):72-5. PubMed ID: 2203175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement components in Nigerians with bronchial asthma.
    Onyemelukwe GC
    Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary cardiomyopathies. II. Levels of immunoglobulins IgG, IgM and IgA and C 3 fraction of the complement in the serum of patients with primary cardiomyopathy].
    Pietrzak M; Krzemínska-Pakuła M; Zebrowski A; Szymankiewicz M
    Pol Arch Med Wewn; 1986 Feb; 75(2):109-15. PubMed ID: 3748828
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
    Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
    J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexplained intrauterine fetal death is accompanied by activation of complement.
    Richani K; Romero R; Soto E; Espinoza J; Nien JK; Chaiworapongsa T; Refuerzo J; Blackwell S; Edwin SS; Santolaya-Forgas J; Mazor M
    J Perinat Med; 2005; 33(4):296-305. PubMed ID: 16207114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of hypertrophic cardiomyopathy to dilated cardiomyopathy--a case reports and review of the literatures.
    Chang KH; Ha JW; Chung NS; Cho SY
    Yonsei Med J; 1998 Feb; 39(1):61-6. PubMed ID: 9529987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.